{rfName}
In

Indexed in

License and use

Altmetrics

Analysis of institutional authors

Duarte RCorresponding Author

Share

April 23, 2019
Publications
>
Article
Bronze

Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019

Publicated to:BONE MARROW TRANSPLANTATION. 54 (10): 1525-1552 - 2019-10-01 54(10), DOI: 10.1038/s41409-019-0516-2

Authors: Duarte RF, Labopin M, Bader P, Basak GW, Bonini C, Chabannon C, Corbacioglu S, Dreger P, Dufour C, Gennery AR, Kuball J, Lankester AC, Lanza F, Montoto S, Nagler A, Peffault de Latour R, Snowden JA, Styczynski J, Yakoub-Agha I, Kröger N, Mohty M, European Society for Blood and Marrow Transplantation (EBMT)

Affiliations

Barts and The London NHS Trust - Author
Barts Hlth NHS Trust, London, England - Author
Cha Sheva Med Ctr, Tel Hashomer, Israel - Author
Chaim Sheba Medical Center Israel - Author
Ctr Invest Clin Biotherapies, Marseille, France - Author
Giannina Gaslini Childrens Hosp, Genoa, Italy - Author
Goethe Univ Hosp, Frankfurt, Germany - Author
Great North Children's Hospital - Author
Great North Childrens Hosp, Newcastle Upon Tyne, Tyne & Wear, England - Author
Heidelberg Univ, Med Klin 5, Heidelberg, Germany - Author
Hop St Antoine, EBMT Paris Study Off, Paris, France - Author
Hopital Saint-Antoine - Author
Hospital Universitario Puerta de Hierro - Author
Inst Paoli Calmettes, Marseille, France - Author
Institut Paoli-Calmettes - Author
IRCCS Istituto Giannina Gaslini - Ospedale Pediatrico - Author
Klinikum und Fachbereich Medizin Johann Wolfgang Goethe-Universitat Frankfurt am Main - Author
Leiden Univ, Med Ctr, Willem Alexander Childrens Hosp, Leiden, Netherlands - Author
Leiden University Medical Center - LUMC - Author
Lille Inflammation Research International Center - Author
Ludwik Rydygier Collegium Medicum in Bydgoszcz - Author
Med Univ Warsaw, Warsaw, Poland - Author
Medical University of Warsaw - Author
Nicolaus Copernicus Univ, Coll Med, Bydgoszcz, Poland - Author
Osped San Raffaele, Sci Inst, Milan, Italy - Author
Paris Diderot Univ, St Louis Hosp, Paris, France - Author
Romagna Transplant Network - Author
Romagna Transplant Network, Ravenna, Italy - Author
Sheffield Teaching Hosp NHS Fdn Trust, Sheffield, S Yorkshire, England - Author
Sheffield Teaching Hospitals NHS Foundation Trust - Author
Sorbonne Univ, Hop St Antoine, Paris, France - Author
Univ Autonoma Madrid, Hosp Univ Puerta de Hierro Majadahonda, Madrid, Spain - Author
Univ Hosp Eppendorf, Hamburg, Germany - Author
Univ Lille, INSERM U995, LIRIC, CHU Lille, F-59000 Lille, France - Author
Univ Med Ctr Utrecht, Utrecht, Netherlands - Author
Univ Regensburg, Regensburg, Germany - Author
Univ Vita Salute San Raffaele, Milan, Italy - Author
Universita Vita-Salute San Raffaele - Author
Universität Heidelberg - Author
Universität Regensburg - Author
Universitatsklinikum Hamburg-Eppendorf und Medizinische Fakultat - Author
Universite Paris 7- Denis Diderot - Author
University Medical Center Utrecht - Author
See more

Abstract

© 2019, Springer Nature Limited. This is the seventh special EBMT report on the indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders. Our aim is to provide general guidance on transplant indications according to prevailing clinical practice in EBMT countries and centres. In order to inform patient decisions, these recommendations must be considered together with the risk of the disease, the risk of the transplant procedure and the results of non-transplant strategies. In over two decades since the first report, the EBMT indications manuscripts have incorporated changes in transplant practice coming from scientific and technical developments in the field. In this same period, the establishment of JACIE accreditation has promoted high quality and led to improved outcomes of patient and donor care and laboratory performance in transplantation and cellular therapy. An updated report with operating definitions, revised indications and an additional set of data with overall survival at 1 year and non-relapse mortality at day 100 after transplant in the commonest standard-of-care indications is presented. Additional efforts are currently underway to enable EBMT member centres to benchmark their risk-adapted outcomes as part of the Registry upgrade Project 2020 against national and/or international outcome data.

Keywords

Acute lymphoblastic-leukemiaAcute myeloid-leukemiaBone-marrow-transplantationCord-blood transplantationHigh-dose chemotherapyLong-term outcomesLymphoma working partyMinimal residual diseaseSevere aplastic-anemiaUnrelated donor transplantation

Quality index

Bibliometric impact. Analysis of the contribution and dissemination channel

The work has been published in the journal BONE MARROW TRANSPLANTATION due to its progression and the good impact it has achieved in recent years, according to the agency WoS (JCR), it has become a reference in its field. In the year of publication of the work, 2019, it was in position 3/24, thus managing to position itself as a Q1 (Primer Cuartil), in the category Transplantation. Notably, the journal is positioned above the 90th percentile.

From a relative perspective, and based on the normalized impact indicator calculated from World Citations provided by WoS (ESI, Clarivate), it yields a value for the citation normalization relative to the expected citation rate of: 9.47. This indicates that, compared to works in the same discipline and in the same year of publication, it ranks as a work cited above average. (source consulted: ESI Nov 14, 2024)

This information is reinforced by other indicators of the same type, which, although dynamic over time and dependent on the set of average global citations at the time of their calculation, consistently position the work at some point among the top 50% most cited in its field:

  • Weighted Average of Normalized Impact by the Scopus agency: 13.08 (source consulted: FECYT Feb 2024)
  • Field Citation Ratio (FCR) from Dimensions: 110.16 (source consulted: Dimensions Aug 2025)

Specifically, and according to different indexing agencies, this work has accumulated citations as of 2025-08-09, the following number of citations:

  • WoS: 177
  • Scopus: 276

Impact and social visibility

From the perspective of influence or social adoption, and based on metrics associated with mentions and interactions provided by agencies specializing in calculating the so-called "Alternative or Social Metrics," we can highlight as of 2025-08-09:

  • The use, from an academic perspective evidenced by the Altmetric agency indicator referring to aggregations made by the personal bibliographic manager Mendeley, gives us a total of: 376.
  • The use of this contribution in bookmarks, code forks, additions to favorite lists for recurrent reading, as well as general views, indicates that someone is using the publication as a basis for their current work. This may be a notable indicator of future more formal and academic citations. This claim is supported by the result of the "Capture" indicator, which yields a total of: 375 (PlumX).

With a more dissemination-oriented intent and targeting more general audiences, we can observe other more global scores such as:

  • The Total Score from Altmetric: 79.6.
  • The number of mentions on the social network Facebook: 1 (Altmetric).
  • The number of mentions on the social network X (formerly Twitter): 96 (Altmetric).
  • The number of mentions in news outlets: 1 (Altmetric).

It is essential to present evidence supporting full alignment with institutional principles and guidelines on Open Science and the Conservation and Dissemination of Intellectual Heritage. A clear example of this is:

  • The work has been submitted to a journal whose editorial policy allows open Open Access publication.

Leadership analysis of institutional authors

This work has been carried out with international collaboration, specifically with researchers from: France; Germany; Israel; Italy; Netherlands; Poland; United Kingdom.

There is a significant leadership presence as some of the institution’s authors appear as the first or last signer, detailed as follows: First Author (DUARTE PALOMINO, RAFAEL FRANCISCO) .

the author responsible for correspondence tasks has been DUARTE PALOMINO, RAFAEL FRANCISCO.